Latest Neuraminidase inhibitors Stories
BIRMINGHAM, Ala., Sept. 21 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received a request for proposal (RFP) from the U.S.
BIRMINGHAM, Ala., Sept. 21 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S.
Researchers reported on Sunday a new experimental flu drug that can stop the swine flu virus from infecting cells and it even seems capable of keeping it from mutating into drug-resistant forms.
SAN FRANCISCO, Sept. 13 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that two new observational studies concluded that influenza patients treated with Tamiflu(R) (oseltamivir phosphate) had significantly higher survival rates than untreated patients.
SAN FRANCISCO, Sept.
Treating people with H1N1 flu with anti-virals oseltamivir and zanamivir should only be considered for those at high risk of complications, U.S.
SAN FRANCISCO, Sept. 9 /PRNewswire-USNewswire/ -- Blue Shield of California announced today that it will cover the administrative costs of the H1N1 virus (swine flu) vaccine for all its members, regardless of which plan they have.
LOURES, Portugal, September 8 /PRNewswire/ -- Hovione is pleased to announce that its TwinCaps(R) inhaler licensees Daiichi Sankyo Co.
EMERYVILLE, Calif., Sept.
EMERYVILLE, Calif., Aug. 25 /PRNewswire/ -- Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its management team, naming Michael D. Coffee, Senior Vice President, Sales and Marketing, and Amy K. Patick, PhD, Vice President, Research. Mr.
More Images (1 images) »